All In Biotech

Drug Trial Radar · NCT02227290

Pediatric Subjects With Tinea Corporis

A Phase 4, Double-Blind, Randomized, Vehicle-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin (Naftifine Hydrochloride) Cream, 2% in Pediatric Subjects With Tinea Corporis

Last checked: Nov 20, 2026Latest source record: Oct 28, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 230 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

230

Actual

Start

Aug 2014

Primary completion

Nov 2015

Study completion Dec 2015

Sponsor

Lead sponsor
Merz North America, Inc.Industry
Sponsor type
Industry
First posted
Aug 28, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.

Conditions

  • Tinea Corporis

Interventions

  • Naftin CreamDrug

  • Placebo CreamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EfficacyTime frame: Day 21

Locations

19 sites in 5 countries. Site status is shown where the registry gives one.

  • Merz Investigative Site#001316

    Tucson, Arizona

  • Investigative Site# 0010320

    Encino, California

  • Merz Investigative Site#001313

    Fremont, California

  • Merz Investigative Site#001301

    San Diego, California

  • Merz Investigative Site#001312

    Miami, Florida

  • Merz Investigative Site#001311

    Miami, Florida

  • Merz Investigative Site #001310

    Miramar, Florida

  • Merz Investigative Site#001307

    Saint Joseph, Missouri

  • Merz Investigative Site#001309

    Omaha, Nebraska

  • Merz Investigative Site#001314

    Henderson, Nevada

  • Merz Investigative Site#001126

    Raleigh, North Carolina

  • Merz Investigative Site#001293

    Winston-Salem, North Carolina

  • Investigative Site# 0010319

    Gresham, Oregon

  • Merz Investigative Site#001097

    Nashville, Tennessee

  • Merz Investigative Site#180002

    San Cristobal, Dominican Republic

  • Merz Investigative Site# 180001

    Santo Domingo, Dominican Republic

  • Merz Investigative Site#504001

    San Pedro Sula, Honduras

  • Merz Investigative Site#507001

    Panama City, Panama

  • Merz Investigative Site#001279

    Cidra, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.